Jennifer Dumont/LinkedIn
Jul 6, 2026, 12:43
Jennifer Dumont: WFH 2026 Congress Highlights – Expert Insights on Hemophilia Care
Jennifer Dumont, Medical Strategy Lead, Rare Blood Disorders Portfolio, shared a post on LinkedIn:
“WFH 2026 Congress Highlights: Expert Insights on Hemophilia Care
Discover key takeaways from the 2026 World Federation of Hemophilia Congress in our latest podcast conversation. I’m joined by two distinguished experts:
- Dr. Robert Sidonio, Professor of Pediatrics, Emory University and Clinical Director & Director of Clinical Research Hemostasis/Thrombosis at Emory University
- Dr. Assad Haffar, Humanitarian Aid and Medical Training Director, World Federation of Hemophilia
In this episode, Drs. Haffar and Sidonio explore:
- Progress and impact of the WFH humanitarian Aid Program
- Joint health and outcomes in hemophilia
- How hemophilia therapies are transforming quality of life
- Addressing challenges in special hemophilia sub-populations
- Managing the complexities of aging population with bleeding disorders
Whether you’re a healthcare professional, researcher, or advocate in the rare disease community, this conversation offers valuable perspectives on the evolving landscape of hemophilia care.
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 13:37Rachad Zayat: Acute PE Study Finds USAT Associated With Better In-Hospital Outcomes
-
Jul 6, 2026, 13:28Inna Vilshanivska: Sharing Ukraine’s Experience in Blood Donor Retention at the ISBT 2026
-
Jul 6, 2026, 13:10Arun V. J.: Did You Know A Glass Of Water is The Best Way To Retain A Blood Donor?
-
Jul 6, 2026, 13:10Javed Anees: The Hidden Power of Biotin in Modern Medicine
-
Jul 6, 2026, 12:46Saneha Anjum Shaikh: Red Cell Aliquoting – Precision in Transfusion Medicine
-
Jul 6, 2026, 12:39Muhammad Hamza: Can Hemolysis Affect Laboratory Results?
-
Jul 6, 2026, 12:32Syed A. Rizvi: Natural Blood Thinners – What Does the Science Really Say
-
Jul 6, 2026, 12:27Abdul Mannan: Perioperative Bridging of Warfarin Patients Is a Risk-Based Decision
-
Jul 6, 2026, 12:20Wolfgang Miesbach: ISTH 2026 Marks a New Era in Immune Thrombocytopenia Management